塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/17 | 6,510 | 6,600 | 6,486 | 6,529 | +48 | +0.7% | 1,625,500 |
2021/08/16 | 6,520 | 6,534 | 6,420 | 6,481 | -55 | -0.8% | 1,242,100 |
2021/08/13 | 6,504 | 6,554 | 6,436 | 6,536 | +33 | +0.5% | 1,697,400 |
2021/08/12 | 6,454 | 6,563 | 6,353 | 6,503 | +71 | +1.1% | 2,715,800 |
2021/08/11 | 6,560 | 6,738 | 6,321 | 6,432 | -2 | ±0% | 6,503,200 |
2021/08/10 | 6,076 | 6,454 | 6,063 | 6,434 | +396 | +6.6% | 5,321,300 |
2021/08/06 | 5,773 | 6,099 | 5,765 | 6,038 | +315 | +5.5% | 4,171,400 |
2021/08/05 | 5,690 | 5,738 | 5,673 | 5,723 | +54 | +1% | 597,200 |
2021/08/04 | 5,705 | 5,748 | 5,640 | 5,669 | -52 | -0.9% | 1,007,600 |
2021/08/03 | 5,811 | 5,811 | 5,688 | 5,721 | -177 | -3% | 1,766,400 |
2021/08/02 | 5,828 | 5,925 | 5,810 | 5,898 | +146 | +2.5% | 812,900 |
2021/07/30 | 5,849 | 5,850 | 5,752 | 5,752 | -136 | -2.3% | 1,146,400 |
2021/07/29 | 5,956 | 5,971 | 5,875 | 5,888 | -55 | -0.9% | 723,500 |
2021/07/28 | 5,939 | 5,988 | 5,894 | 5,943 | -7 | -0.1% | 1,002,100 |
2021/07/27 | 6,000 | 6,017 | 5,921 | 5,950 | -20 | -0.3% | 1,473,900 |
2021/07/26 | 5,869 | 5,970 | 5,802 | 5,970 | +185 | +3.2% | 1,765,900 |
2021/07/21 | 5,817 | 5,838 | 5,752 | 5,785 | +39 | +0.7% | 868,800 |
2021/07/20 | 5,750 | 5,778 | 5,684 | 5,746 | +52 | +0.9% | 1,121,700 |
2021/07/19 | 5,700 | 5,733 | 5,662 | 5,694 | -28 | -0.5% | 788,800 |
2021/07/16 | 5,757 | 5,771 | 5,713 | 5,722 | -100 | -1.7% | 997,400 |
2021/07/15 | 5,911 | 5,929 | 5,806 | 5,822 | -69 | -1.2% | 1,012,900 |
2021/07/14 | 5,821 | 5,899 | 5,813 | 5,891 | +51 | +0.9% | 958,500 |
2021/07/13 | 5,833 | 5,871 | 5,819 | 5,840 | +16 | +0.3% | 810,100 |
2021/07/12 | 5,819 | 5,829 | 5,762 | 5,824 | +146 | +2.6% | 1,182,500 |
2021/07/09 | 5,711 | 5,720 | 5,601 | 5,678 | -97 | -1.7% | 1,951,800 |
2021/07/08 | 5,844 | 5,929 | 5,775 | 5,775 | -45 | -0.8% | 2,124,500 |
2021/07/07 | 5,771 | 5,830 | 5,736 | 5,820 | +52 | +0.9% | 1,475,100 |
2021/07/06 | 5,746 | 5,770 | 5,721 | 5,768 | +22 | +0.4% | 596,300 |
2021/07/05 | 5,764 | 5,782 | 5,726 | 5,746 | -16 | -0.3% | 757,200 |
2021/07/02 | 5,778 | 5,804 | 5,743 | 5,762 | ±0 | ±0% | 877,200 |
2021/07/01 | 5,793 | 5,795 | 5,726 | 5,762 | -29 | -0.5% | 835,400 |
2021/06/30 | 5,819 | 5,848 | 5,761 | 5,791 | -6 | -0.1% | 1,275,300 |
2021/06/29 | 5,768 | 5,808 | 5,733 | 5,797 | -30 | -0.5% | 1,145,300 |
2021/06/28 | 5,848 | 5,848 | 5,744 | 5,827 | +121 | +2.1% | 1,893,500 |
2021/06/25 | 5,700 | 5,719 | 5,666 | 5,706 | +48 | +0.8% | 649,600 |
2021/06/24 | 5,613 | 5,678 | 5,590 | 5,658 | +34 | +0.6% | 464,100 |
2021/06/23 | 5,640 | 5,708 | 5,620 | 5,624 | -53 | -0.9% | 780,500 |
2021/06/22 | 5,577 | 5,680 | 5,577 | 5,677 | +159 | +2.9% | 1,369,900 |
2021/06/21 | 5,585 | 5,593 | 5,490 | 5,518 | -147 | -2.6% | 1,387,000 |
2021/06/18 | 5,707 | 5,715 | 5,650 | 5,665 | -32 | -0.6% | 1,234,200 |
2021/06/17 | 5,807 | 5,829 | 5,694 | 5,697 | -77 | -1.3% | 995,100 |
2021/06/16 | 5,799 | 5,874 | 5,762 | 5,774 | -63 | -1.1% | 1,299,700 |
2021/06/15 | 5,793 | 5,854 | 5,788 | 5,837 | +93 | +1.6% | 1,167,600 |
2021/06/14 | 5,769 | 5,800 | 5,721 | 5,744 | -47 | -0.8% | 1,085,800 |
2021/06/11 | 5,791 | 5,846 | 5,681 | 5,791 | -48 | -0.8% | 2,170,400 |
2021/06/10 | 5,764 | 6,086 | 5,759 | 5,839 | +192 | +3.4% | 4,134,700 |
2021/06/09 | 5,599 | 5,655 | 5,586 | 5,647 | +52 | +0.9% | 790,800 |
2021/06/08 | 5,625 | 5,657 | 5,587 | 5,595 | -2 | ±0% | 1,021,400 |
2021/06/07 | 5,650 | 5,659 | 5,571 | 5,597 | -30 | -0.5% | 570,500 |
2021/06/04 | 5,603 | 5,634 | 5,576 | 5,627 | +31 | +0.6% | 769,400 |
901~
950
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 240,700円 | +5.7% | +3.9% | 2.38% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 661,000円 | +2.2% | +10.2% | 1.82% | 12.69倍 | 1.28倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 133,500円 | +18.5% | -96.0% | 5.54% | 170.72倍 | 1.56倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 397,600円 | +1.7% | -2.9% | 4.02% | 26.09倍 | 1.37倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 219,600円 | -3.5% | -11.3% | 2.73% | 20.17倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム